China, Coronaviruses, Covid-19, Infectology, Scientific Literature.
Hsueh PR. Arguments in favor of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 Mar 5:105933. 42: Wang J, Wang BJ, Yang JC, Wang MY, Chen C, Luo GX, He WF. [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the